For the V307L KCNQ1 SQT2 mutation, initial in silico data10 were able to reproduce action potential (AP) shortening but did not address directly effects on the QT interval or arrhythmia mechanisms. The gene discussed is KCNQ1; the disease is cardiac arrhythmia.